Translational Biomarker Group

Keyphrases

1. Storage Conditions 100%
2. RNAlater 59%
3. Sample Stability 59%
4. Human Stool Samples 59%
5. Stabilizing Solution 59%
6. Alzheimer's Disease 59%
7. Memory Impairment 59%
8. Alzheime's Disease 59%
9. Post-COVID 59%
10. Microbiological Analysis 59%
11. ELISA Assay 59%
12. Cystatin C (Cys C) 59%
13. Cerebrospinal Fluid Samples 59%
14. Disease Research 59%
15. Method Validation 59%
16. Quality Control Tools 59%
17. Optimal Storage 59%
18. Health Effects 59%
19. Cerebrospinal Fluid 42%
20. Reactive Inhibition 40%
21. Magnetic Separation 40%
22. Stool 40%
23. Biobank 40%
24. DNA Extraction 40%
25. No Significant Difference 40%
26. Polymerase Chain Reaction 40%
27. Fitness for Purpose 40%
28. Microbiome 40%
29. Four-core 29%
30. Human Stool 19%
31. Rapid Freezing 19%
32. DNA Genotek 19%
33. Sample Homogeneity 19%
34. Robust Stability 19%
35. Material Homogeneity 19%
36. Automated DNA Extraction 19%
37. Community Norms 19%
38. DNA Purity 19%
39. Microbial Profile 19%
40. Solution Conditions 19%
41. PerkinElmer 19%
42. Lysis Buffer 19%
43. Biospecimen Processing 19%
44. DNA Yield 19%
45. Microbial Composition 19%
46. Scope of Accreditation 19%
47. Snapping 19%
48. Alpha Diversity 19%
49. Processing Methods 19%
50. Stool Samples 19%
51. Collection Tubes 19%
52. Accreditation 19%
53. Double-stranded DNA (dsDNA) 19%
54. Collection Method 19%
55. Collection Storage 19%
56. Formal Methods 19%
57. Processing Protocol 19%
58. Acceptance Criteria 19%
59. Accurate Identification 19%
60. Microbial Community 19%
61. Freeze-thaw Cycles 17%
62. Adsorption 17%
63. Octapeptide 17%
64. Indirect Sandwich ELISA 17%
65. Technical Standardization 14%
66. SARS-CoV-2 Infection 13%
67. Protease 8%
68. Fit-for-purpose 8%
69. Biological Fluids 8%
70. Mass Spectrometry 8%
71. Specific Monoclonal Antibodies 8%
72. Stability Study 8%
73. Protease Inhibitors 8%
74. Immunoassay 8%
75. Liquid Nitrogen 8%
76. Quality Assessment Tool 8%
77. Truncated Protein 8%
78. C Protein 8%
79. Biospecimens 8%
80. Symptom Persistence 6%
81. Symptomatology 6%
82. Female Gender 6%
83. Quantitative PCR 6%
84. Low Resilience 6%
85. Persistent Symptoms 6%
86. Pandemic Impact 6%
87. COVID-19 Patients 6%
88. Risk Analysis 6%
89. Major Challenges 6%
90. Serological Tests 6%
91. Comorbidity Profile 6%
92. Gel Tubes 6%
93. Loneliness 6%
94. Comorbidity 6%
95. Luxembourgish 6%